Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Breast Tumor Heterogeneity Necessitate Additional HER2 Testing on the Surgical Specimens?

NCT02108561 is registered in ClinicalTrials.gov with Anne Arundel Health System Research Institute as lead sponsor.

NCT NCT02108561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02108561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Breast Tumor Heterogeneity Necessitate Additional HER2 Testing on the Surgical Specimens?
Lead sponsor
Anne Arundel Health System Research Institute
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2018
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer